Ruffo Frank 4
4 · Aclaris Therapeutics, Inc. · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Ruffo Frank
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-02-01+3,875→ 173,747 total - Exercise/Conversion
Restricted Stock Units
2022-02-01−3,875→ 0 total→ Common Stock (3,875 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The shares underlying these restricted stock units vested on February 1, 2022.